Back
Allogene Therapeutics Vs. Protalix BioTherapeutics Industry Stock Comparison
Sell
11
ALLO
Allogene Therapeutics
Last Price:
2.11
Seasonality Move:
6.59%
Buy
80
PLX
Protalix BioTherapeutics
Last Price:
1.67
Seasonality Move:
78.33%
Sell
11
Allogene Therapeutics (ALLO)
is a Sell
Is Allogene Therapeutics a Buy, Sell or Hold?
- The current Allogene Therapeutics [ALLO] share price is $2.05. The Score for ALLO is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- ALLO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
80
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.69. The Score for PLX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALLO Stock Price Chart
What is Allogene Therapeutics's stock price today?
-
The Allogene Therapeutics share price today is $2.05
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALLO is experiencing slight selling pressure.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.69
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing slight buying pressure.
ALLO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 31.82 | Sell |
| Chaikin Money Flow: | -488566 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.38 - 3.02) | Sell |
| Bollinger Bands (100): | (2.39 - 2.95) | Sell |
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 76 | Buy |
| Chaikin Money Flow: | 188555 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.05 - 1.43) | Buy |
| Bollinger Bands (100): | (0.96 - 1.24) | Buy |
ALLO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.46 | Sell |
| 20-day SMA: | 2.68 | Sell |
| 50-day SMA: | 2.72 | Sell |
| 200-day SMA: | 3.14 | Sell |
| 8-day EMA: | 2.38 | Sell |
| 20-day EMA: | 2.59 | Sell |
| 50-day EMA: | 2.67 | Sell |
| 200-day EMA: | 3.04 | Sell |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.44 | Buy |
| 20-day SMA: | 1.28 | Buy |
| 50-day SMA: | 1.15 | Buy |
| 200-day SMA: | 1.19 | Buy |
| 8-day EMA: | 1.49 | Buy |
| 20-day EMA: | 1.33 | Buy |
| 50-day EMA: | 1.2 | Buy |
| 200-day EMA: | 1.22 | Buy |
Allogene Therapeutics Earnings Growth & ALLO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.06 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Allogene Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protalix BioTherapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||